Daxor
5 hedge funds and large institutions have $893K invested in Daxor in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.07% less ownership
Funds ownership: 1.74% → 1.67% (-0.07%)
4% less capital invested
Capital invested by funds: $926K → $893K (-$33K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$29.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$56.1K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.39K |
DXR Hedge Fund Activity: Q3 2022 in Review
5 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q3 2022, worth a combined $893K — down 3.6% from $926K a quarter earlier.
Fund positioning in DXR was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $29.6K. The largest seller was Renaissance Technologies, cutting an estimated $56.1K.
- 5 institutional investors held Daxor (DXR) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $893K of Daxor stock for Q3 2022, down 3.6% quarter-over-quarter.
- 1 fund opened new Daxor positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest Daxor buyer in Q3 2022 was Tower Research Capital (TRC), an estimated $29.6K added.
- The largest Daxor seller in Q3 2022 was Renaissance Technologies, an estimated $56.1K sold.
Based on aggregated 13F filings for Q3 2022.